Publicaciones en colaboración con investigadores/as de University of Twente (16)

2024

  1. What benefit-risk trade-offs are acceptable to rheumatoid arthritis patients during treatment selection? Evidence from a multicountry choice experiment

    RMD Open, Vol. 10, Núm. 1

2023

  1. Long-term outcomes of patients with normal fractional flow reserve and thin-cap fibroatheroma

    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 18, Núm. 13, pp. e1099-e1107

  2. Morphological characteristics of lesions with thin cap fibroatheroma-a substudy from the COMBINE (OCT-FFR) trial

    European heart journal. Cardiovascular Imaging, Vol. 24, Núm. 5, pp. 687-693

2022

  1. Angiography-derived physiology guidance vs usual care in an All-comers PCI population treated with the healing-targeted supreme stent and Ticagrelor monotherapy: PIONEER IV trial design

    American Heart Journal, Vol. 246, pp. 32-43

  2. Thin-Cap Fibroatheroma Rather Than Any Lipid Plaques Increases the Risk of Cardiovascular Events in Diabetic Patients: Insights from the COMBINE OCT-FFR Trial

    Circulation: Cardiovascular Interventions, Vol. 15, Núm. 5, pp. E011728

2021

  1. EEG functional connectivity contributes to outcome prediction of postanoxic coma

    Clinical Neurophysiology, Vol. 132, Núm. 6, pp. 1312-1320

  2. Large between-patient variability in egfr decline before clinical trial enrollment and impact on atrasentan’s efficacy: a post hoc analysis from the SONAR trial

    Journal of the American Society of Nephrology, Vol. 32, Núm. 11, pp. 2731-2734

  3. Thin-cap fibroatheroma predicts clinical events in diabetic patients with normal fractional flow reserve: the COMBINE OCT-FFR trial

    European heart journal, Vol. 42, Núm. 45, pp. 4671-4679

2020

  1. Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk

    American Journal of Human Genetics, Vol. 107, Núm. 5, pp. 837-848

  2. Evolving the comprehensive management of rheumatoid arthritis: identification of unmet needs and development of practical and educational tools

    Clinical and experimental rheumatology, Vol. 38, Núm. 6, pp. 1056-1067

2016

  1. Reducing Microvascular Dysfunction in Revascularized Patients with ST-Elevation Myocardial Infarction by Off-Target Properties of Ticagrelor versus Prasugrel. Rationale and Design of the REDUCE-MVI Study

    Journal of Cardiovascular Translational Research, Vol. 9, Núm. 3, pp. 249-256

2015

  1. Fractional flow reserve and coronary bifurcation anatomy: A novel quantitative model to assess and report the stenosis severity of bifurcation lesions

    JACC: Cardiovascular Interventions, Vol. 8, Núm. 4, pp. 564-574

  2. Prospective assessment of the diagnostic accuracy of instantaneous wave-free ratio to assess coronary stenosis relevance: Results of ADVISE II international, multicenter study (ADenosine vasodilator independent stenosis evaluation II)

    JACC: Cardiovascular Interventions, Vol. 8, Núm. 6, pp. 824-833

2014

  1. Comparison of newer-generation drug-eluting with bare-metal stents in patients with acute ST-segment elevation myocardial infarction: A pooled analysis of the EXAMINATION (clinical evaluation of the xience-V stent in acute myocardial INfArcTION) and COMFORTABLE-AMI

    JACC: Cardiovascular Interventions, Vol. 7, Núm. 1, pp. 55-63

2009

  1. Safety, pharmacokinetics, and pharmacodynamics of the insulin-like growth factor type 1 receptor inhibitor figitumumab (CP-751,871) in combination with paclitaxel and carboplatin

    Journal of Thoracic Oncology, Vol. 4, Núm. 11, pp. 1397-1403

1995

  1. Improved distribution and reduced toxicity of adriamycin bound to albumin-heparin microspheres

    International Journal of Pharmaceutics, Vol. 120, Núm. 1, pp. 51-61